eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2012
vol. 37
 
Share:
Share:

Clinical immunology
Salivary interleukin-1β and Streptococcus mutans level in oral cavity

Sylwia Małgorzata Słotwińska
,
Marzanna Zaleska

(Centr Eur J Immunol 2012; 37 (2): 151-153)
Online publish date: 2012/05/22
Article file
- Salivary interleukin.pdf  [0.07 MB]
Get citation
 
 

Introduction



Contemporary scientific evidence unequivocally points out to the bacterial character of dental caries. Still the multidirectional assays on caries pathogenesis suggest a necessity to consider the role of immunological system in dental caries etiology. Especially interesting are the studies concerning the immunocompromised patients and invalid immune system functions [1-3]. On the other side it is common knowledge that the potentially cariogenic bacteria do not lead to carious disease in every case. The bacterial antigens can affect host organism, provoking immune response. Many pathogens residing in the oral cavity can stimulate immune cells to produce cytokines. Interleukin-1 – one of the most important cytokines in the human immune system – plays pivotal role in the anti-bacterial defense system.

The aim of the presented study was to assess the IL-1 level in saliva, as well as to evaluate the Streptococcus mutans prevalence in the oral cavity.

Material and methods



The study group comprised 86 patients aged 17-56 years, including 52 women (aged 17-56 years) and 34 men (aged 19-56 years). Interleukin-1 concentration (IL-1) was assessed by means of commercially available qualitative enzymatic Quantikine test (R&D System Europe Ltd., Abingdon, Oxon, United Kingdom), based on the immunoenzymatic ELISA assay, according to the manufacturer’s instruction. The test specimens – mixed unstimulated saliva – were collected two hours after breakfast, then frozen and stored in –70°C. Once defrosted, each specimen was centrifuged at 1000 γ for 20 min. The concentration of assessed cytokine was expressed in pg/ml. Streptococci viridans (mutans streptococci) were assessed in saliva collected for about 5 min upon stimulation by chewing paraffin tablet. The bacteriological assay was performed by means of commercially available medium Dentocult SM – Strip Mutans (Orion Diagnostica). The study material was collected and inoculated according to the manufacturer’s recommendations. The results were classed according to the specific key, provided with the diagnostic sets mentioned above. The following classes of Dentocult SM assay were distinguished: 103 (class 0 – uncountable); < 105 (class 1), 105-106 (class 2), > 106 (class 3).

Statistical analysis: to evaluate the correlation between clinical and immunological results the Pearson’s r test was used.



Ethics



The patients and persons from control group gave a consent after details of the protocol were fully explained. The protocol of the study was conforms to the ethical guidelines of the World Medical Association Declaration of Helsinki.

Results



The presence of Streptococci viridans (mutans streptococci) was stated in 71 out of 86 analyzed salivary samples (82.56% patients). In 15 patients no countable amount of Streptococcus mutans was observed. Low bacteria levels (class 1) were recorded in 27 patients (31.40%), while abundant growth (class 2 and 3) was observed in 28 (32.56%) and 16 (18.60%) participants, respectively. In most of the patients (n = 76; 88.37%) the IL-1 salivary concentration belonged to the range of 9 to 11 pg/ml. The IL-1 salivary concentration in the other patients varied between 3 and 9 pg/ml (n = 9; 10.47%), while in only one person it exceeded 11 pg/ml (amounting to 11.50 pg/ml). The statistical analysis of study results revealed significant correlation between IL-1 salivary concentration and Streptococcus mutans level in oral cavity: Pearson coefficient r = 0.47252; P < 0.05 (Fig. 1).

Discussion



Human reaction to the invasion of cariogenic bacteria is mainly based on humoral immune response [4, 5]. Many studies have revealed correlation between serum or salivary immunoglobulin concentration and the advancement of caries [6, 7]. Still the defense factors against caries probably include cellular immune response as well. Antibacterial cellular reaction of T-cells in course of caries is related to the expression of superficial antigens of Streptococcus mutans, mainly class I/II proteins and serotype f rhamnose-glucose polysaccharide, as well as Streptococcus mutans-derived glucosyltransferase D [8]. Cellular immune response (T-cells), similarly to humoral immune response (B-cells), increases when the cell membrane of lymphocytes gets bound to glucosyltransferase D [9]. The studies concerning these factors aimed at developing dental caries vaccine. Yet these attempts remained unsuccessful, mainly because of numerous side effects. Eventually the adverse effects surpassed expected benefits. The trials on this area remain still in the experimental phase. In HIV-positive children a significant correlation has been observed between increased DMFT/dmft values and decreased CD4/CD8 proportion (below 0.5) [1, 3]. Children of lower caries frequency present significantly higher levels of cellular immune response indicators as compared to the children exhibiting high caries frequency [10]. The correlation between caries advancement and major histocompatibility complex (MHC) antigens has also been subject of studies [11]. The multidirectional character of discussion concerning the role of immune system in dental caries etiopathogenesis indicates necessity for further studies on this field [12, 13]. An especially important element of antibacterial defense are cytokines [14-16]. The presented study is the first to discuss the possible correlation between cariogenic bacteria prevalence in oral cavity and salivary IL-1 concentration. It cannot be excluded that the oral cavity colonization by cariogenic bacteria is secondary to the genetically determined specific cytokines concentration. On the other hand, many antigens present in the oral cavity can stimulate cytokine production. In the presented study in most of the patients (n = 76; 88.37%) the IL-1 salivary concentration varied between 9 and 11 pg/ml, that could be recognized as a physiological range of this cytokine in the studied population. The statistical analysis of results revealed a relevant correlation between salivary IL-1 concentration and Streptococcus mutans level in oral cavity, thus suggesting the IL-1 significance in caries etiopathogenesis or denoting the modulation of cytokine concentration by bacterial antigens. It’s hard to formulate an unambiguous conclusion. The susceptibility or immunity against caries is definitely determined by immune forces of human body. The results presented above are encouraging and raise hope for possible new perspectives in dental caries prophylaxis and treatment.

References



 1. Vieira AR, de Souza IP, Modesto A, et al. (1998): Gingival status of HIV+ children and the correlation with caries incidence and immunologic profile. Pediatr Dent 20: 169-172.

 2. Russell MW (1992): Immunization against dental caries. Curr Opin Dent 9: 72-80.

 3. Hicks MJ, Flaitz CM, Carter AB, et al. (2000): Dental caries in HIV-infected children: a longitudinal study. Pediatr Dent 22: 359-364.

 4. Gregory RL, Michalek SM, Filler SJ, et al. (1985): Prevention of Streptococcus mutans colonization by salivary IgA antibodies. J Clin Immunol 5: 55-62.

 5. Camling E, Gahnberg L, Krasse B, Wallman C (1991): Crevicular IgG antibodies and Streptococcus mutans on erupting human first permanent molars. Arch Oral Biol 36: 703-708.

 6. Tenovuo J, Aaltonen AS (1991): Antibody responses to mutans streptococci in children. Proc Finn Dent Soc 87: 449-461.

 7. Russell MW, Hajishengallis G, Childers NK, Michalek SM (1999): Secretory immunity in defense against cariogenic mutans streptococci. Caries Res 33: 4-15.

 8. Engels-Deutsch M, Pini A, Yamashita Y, et al. (2003): Insertional inactivation of pac and rmlB genes reduces the release of tumor necrosis factor alpha, interleukin-6, and interleukin-8 induced by Streptococcus mutans in monocytic, dental pulp, and periodontal ligament cells. Infect Immun 71: 5169-5177.

 9. Chia JS, You CM, Hu CY, et al. (2001): Human T cells responses to the glucosylotransferases of Streptococcus mutans. Clin Diag Lab Immun 8: 441-445.

10. Parkash H, Sharma A, Banerjee U, et al. (1993): Differential cell-mediated immune response to Streptococcus mutans in children with low and high dental caries. Indian Pediatr 30: 991-995.

11. Yoshiba N, Yoshiba K, Iwaku M, Ozawa H (1998): Immunohistochemical localizations of class II antigens and nerve fibers in human carious teeth: HLA-DR immunoreactivity in Schwann cells. Arch Histol Cytol 61: 343-352.

12. Smith GE (1987): Immunity and dental caries: can vaccines prevent cavities? Sci Prog 71: 239-248.

13. Tenovuo J (1989): Nonimmunoglobulin defense factor in human saliva. In: Human saliva: clinical chemistry and microbiology. Vol. II. Tenovuo J (ed.). CRC Press, Inc., Boca Raton; 55-91.

14. Benabdelmoumene S, Dumont S, Petit C, et al. (1991): Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect Immun 59: 3261-3266.

15. Horst OV, Horst JA, Samudrala R, Dale BA (2011): Caries induced cytokine network in the odontoblast layer of human teeth. BMC Immunol 12: 9.

16. Farges JC, Carrouel F, Keller JF, et al. (2011): Cytokine production by human odontoblast-like cells upon Toll-like receptor-2 engagement. Immunobiology 216: 513-517.
Copyright: © 2012 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.